Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
14 Jul 2017 FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy Palliative and supportive care
13 Jul 2017 The EU-Funded MiRoR Project Will Transform Clinical Research Practice and Increase its Value Bioethics, legal and economic issues
12 Jul 2017 NICE Terminates Appraisals for Daratumumab with Lenalidomide and Dexamethasone, Bortezomib in Relapsed Multiple Myeloma, and Ibrutinib for Untreated CLL Haematologic malignancies - Anticancer agents & Biologic therapy
11 Jul 2017 FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease Cancer in Special Situations - Haematologic malignancies
10 Jul 2017 First-Line Nivolumab in Stage IV or Recurrent NSCLC with a PD-L1 Expression Level of 5% or More Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
07 Jul 2017 FDA Grants Marketing Approval to the Praxis Extended RAS Panel Personalised medicine - Anticancer agents & Biologic therapy
06 Jul 2017 NICE Develops a Medtech Innovation Briefing on L-Dex U400 for Lymphoedema After Breast Cancer Treatment Breast cancer - Diagnosis, Imaging and Staging
05 Jul 2017 Metastatic Colorectal Cancer: Beyond RAS and BRAF Translational research - Gastrointestinal cancers
04 Jul 2017 EMA Recommends Extension of Indications for Fulvestrant Breast cancer - Anticancer agents & Biologic therapy
03 Jul 2017 FDA Approves Betrixaban for the Prophylaxis of VTE in Adult Patients Palliative and supportive care
01 Jul 2017 World GI 2017 Press Release: Right-sided Colorectal Tumours: An Internal Radiation Advantage Gastrointestinal cancers
30 Jun 2017 FDA Approves Rituximab Plus Hyaluronidase Combination for Treatment of FL, DLBCL and CLL Haematologic malignancies - Anticancer agents & Biologic therapy
30 Jun 2017 World GI 2017 Press Release: Zoning in on Specifics of Mediterranean Diet for Colorectal Health Gastrointestinal cancers
28 Jun 2017 EMA Recommends Extensions of Therapeutic Indications for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Tivozanib Hydrochloride Monohydrate Genitourinary cancers - Anticancer agents & Biologic therapy